Adriamycin에 의해 유발된 가역적인 심근병증 1례
- Author(s)
- 장용석; 조주연; 허지안; 도영록; 송홍석
- Keimyung Author(s)
- Do, Young Rok; Song, Hong Suk; Cho, Ju Yeon
- Department
- Dept. of Dentistry (치과학)
Dept. of Internal Medicine (내과학)
- Journal Title
- Keimyung Medical Journal
- Issued Date
- 2002
- Volume
- 21
- Issue
- 1
- Keyword
- Adriamycin; Cardiomyopathy
- Abstract
- Adriamycin is a chemotherapeutic agent highly effective against a
wide range of neoplasms. A primary limiting factor to the administration of this
drug is a cardiotoxicity, which frequently develops when the cumulative dose
exceeds 500 mg/m2. Cardiomyopathy, which may develop even after a year of discontinuation
of adriamycin therapy, is though to be rapidly progressive and unresponsive
to standard cardiac therapy. We experienced a case of adriamycininduced
cardiomyopathy. A 53-year-old male patient who received 337 mg/m2 of
adriamycin experienced congestive heart failure at 5 years since the completion of
the therapy. Endomyocardial biopsy showed vacuolization of myocytes and focal
fibrotic areas. The patient responded to diuretics, inotrophic agents, and an
angiotensin converting enzyme inhibitors, and resolution of left ventricular dysfunction
was verified by plain chest radiography and echocardiography.
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.